Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Workflow Gu
2026-06-19
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides a defined, affinity-purified reagent for detecting HMGB1 protein in human, mouse, and rat samples. It is suitable for Western blot, immunohistochemistry, and flow cytometry, but must not be used for diagnostic or clinical purposes.
Dinaciclib Targets VHL-Deficient Renal Carcinoma via Synthet
2026-06-19
This study uncovers that Dinaciclib, a cyclin-dependent kinase inhibitor, selectively induces cytotoxicity in VHL-deficient clear cell renal cell carcinoma (CC-RCC) through synthetic lethality. The findings highlight a promising therapeutic strategy that spares normal and VHL-restored cells, with significant implications for targeted kidney cancer treatment.
PD98059: MEK Inhibitor Workflows for Cell Cycle and Neuropro
2026-06-18
PD98059, a selective and reversible MEK inhibitor, enables precise dissection of MAPK/ERK signaling in cancer and neuroprotection models. This guide delivers stepwise workflows, troubleshooting insights, and evidence-driven applications to help researchers maximize reproducibility and mechanistic clarity when employing PD98059 in cell-based and animal assays.
MHY1485: Advancing mTOR Activation in Translational Research
2026-06-18
Explore how MHY1485, a potent mTOR activator from APExBIO, is redefining translational research workflows. This article integrates mechanistic insights from recent cancer biology with practical guidance for autophagy assays, cell survival studies, and ovarian follicle development research. Referencing the latest findings on the LMP2A-mTORC1-GCNT3 axis in nasopharyngeal carcinoma, we chart a strategic path for leveraging MHY1485 in next-generation biomedical innovation.
Flumequine in Quantitative Drug Response: Topoisomerase II A
2026-06-17
Explore how Flumequine, a leading DNA topoisomerase II inhibitor, empowers precision drug response quantification and advanced assay design. This article uniquely bridges mechanism, IC50 evidence, and the latest in vitro evaluation strategies.
Salvianolic Acid B Inhibits LH2-Driven Collagen Synthesis in
2026-06-17
This study elucidates how Salvianolic acid B (Dan Shen Suan B) directly inhibits lysyl hydroxylase 2 (LH2), disrupting collagen cross-linking and extracellular matrix remodeling in pulmonary fibrosis models. The findings highlight a molecularly targeted, natural approach to antifibrotic intervention, with practical implications for fibrosis research.
SD 169 (indole-5-carboxamide): Beyond Inhibition—Novel Mecha
2026-06-16
Discover how SD 169 (indole-5-carboxamide) enables advanced control of p38 MAPK signaling through dual-action inhibition and activation loop dephosphorylation. This in-depth analysis reveals new mechanistic insights and assay strategies vital for type 1 diabetes and axonal regeneration research.
Resolving RNA Synthesis Challenges with T7 RNA Polymerase (K
2026-06-16
This article delivers a scenario-driven, evidence-based guide for biomedical researchers and lab technicians addressing common bottlenecks in RNA synthesis, transfection, and workflow reproducibility. Through five real-world Q&A blocks and data-backed analysis, it demonstrates how T7 RNA Polymerase (SKU K1083)—a recombinant enzyme expressed in E. coli—delivers robust, high-fidelity results for in vitro transcription, RNA vaccine production, and advanced RNAi studies.
Everolimus (RAD001): Applied mTOR Inhibition in Cancer Resea
2026-06-15
Everolimus (RAD001) empowers researchers to dissect mTOR pathway inhibition with precision, enabling robust apoptosis and proliferation studies in cancer models. This guide details optimized workflows, troubleshooting, and insights drawn from cutting-edge reference studies to elevate experimental outcomes.
Photodynamic Targeting of Dental Biofilms with Liposomal p-T
2026-06-15
Liang et al. present a novel liposome-encapsulated, blue light-activated p-toluquinone system for precise eradication of multispecies dental biofilms. Their approach demonstrates targeted delivery, pH-responsive selectivity, and strong antimicrobial efficacy, offering a promising alternative to traditional oral infection management.
Comparative In Vitro Activity of Temafloxacin vs. Quinolones
2026-06-14
The reference study systematically compares the in vitro potency of temafloxacin, ciprofloxacin, and ofloxacin against a broad panel of Gram-negative pathogens. Key findings reveal temafloxacin's notably low MICs for respiratory and enteric bacteria, underscoring the evolution of quinolone antibiotics and informing future experimental choices in antimicrobial research.
Nonivamide (Capsaicin Analog): Advanced Workflows in Cancer
2026-06-13
Nonivamide, a potent capsaicin analog, offers selective TRPV1 activation for precise modeling of cancer cell apoptosis and neuroimmune pathways. This guide delivers actionable workflows, troubleshooting insights, and unique use-case differentiation, enabling researchers to harness Nonivamide’s full experimental potential.
Primidone (Mysoline): Translational Advances in TRPM3 & RIPK
2026-06-12
Primidone (Mysoline) is redefining translational research as a dual TRPM3 and RIPK1 inhibitor, with validated impact in neurodegenerative and gynecological disease models. Learn how robust protocols and troubleshooting tips can optimize your experimental outcomes using APExBIO’s high-purity Primidone.
SAG Mitigates Mitochondrial Dysfunction in Frataxin-Deficien
2026-06-12
Vicente-Acosta et al. (2022) demonstrate that pharmacological activation of the Hedgehog pathway with the Smoothened agonist SAG rescues mitochondrial function and reduces neurotoxicity in frataxin-deficient human astrocytes, a cellular model of Friedreich’s ataxia. Their work highlights the potential of Hedgehog pathway modulation as a neuroprotective strategy in rare neurodegenerative disease contexts.
Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec
2026-06-11
Cy3 NHS ester (non-sulfonated) provides a reliable solution for fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is well-suited for workflows that tolerate organic co-solvents, but is not recommended for delicate proteins or strictly aqueous protocols. Researchers can achieve sensitive detection in imaging and analytical assays when following solvent and storage best practices.
466 records 15/32 page Previous Next First page 上5页 1112131415 下5页 Last page